The proteinase of the human endogenous retrovirus K (HERV-K) shows similarity to retrovirus aspartic proteinases. It is translated from a transcript composed of gag and prt. The proteinase was expressed either as fulllength native protein or as truncated protein in Eseheriehia eoli. Functional protein was demonstrated by its autocatalytic cleavage into an 18 kDa fragment recognized by a polyclonal antiserum. This autocatalytic cleavage was specifically inhibited by a human immunodeficiency virus type 1 proteinase inhibitor. The HERV-K proteinase expressed in E. coil was capable of cleaving HERV-K Gag translated in vitro. Major protein fragments of 39 and 30 kDa, and minor protein fragments of 26, 22 and 21 kDa were obtained. Similar fragments are also observed in the human teratocarcinoma cell line Teral. Our data suggest that the HERV-K proteinase is functionally equivalent to other retrovirus proteinases and thus probably functions in the processing of Gag precursor protein.
The human endogenous retrovirus K (HERV-K) family has been found to include members with open reading frames (ORFs) representing gag, prt, pol and env (Ono et al., 1986; Mueller-Lantzsch et al., 1993; L6wer et aI., 1993) . Recently we were able to demonstrate a correlation between the expression of HERV-K gag sequences and seminomas in humans (Sauter et al., 1995) . Likewise, we showed that HERV-K Gag protein was expressed in the human teratocarcinoma cell line Teral Sauter et al., 1995) . Moreover, particles associated with Teral that resemble retroviruslike particles and stain positive for HERV-K Gag indicate that the ORFs are indeed expressed . At present, the biological function of these particles remains unclear. Retrovirus structural proteins are synthesized and assembled as polyproteins and proteolytically cleaved in the nascent virus particle from these precursors by the virus proteinase. Proteolytic cleavage of Gag is a prerequisite for the morphological conversion of the immature non-infectious virion to the mature infectious virion. Therefore, it was of particular interest to us to study further the enzyme that catalyses this processing reaction.
Retrovirus proteinases belong to the family of aspartic * Author for correspondence. Fax +49 6841 16 3980.
proteinases. They consist of about 99-125 amino acids and are active as homodimers. In mammalian retroviruses the proteinase is encoded as part of the Gag Pol (or Gag-Prt) polyprotein. Previous studies have indicated that the HERV-K proteinase is encoded by its own reading frame located between gag and pol (ORF 3 ; Fig.  1 ). In the present study we have further investigated the catalytic function of the bacterially expressed HERV-K proteinase.
In a first set of experiments, the HERV-K proteinase was expressed from different constructs in Escherichia coli either as a TrpE fusion protein or as non-fusion protein. Plasmids pKP1.3 and pPROT3423 contain the complete prt gene driven by the bacterial trpE promoter; pKP1.3 encodes the C-terminal Gag sequence linked to the N terminus ofORF 3 , while pPROT3423 encodes the N-terminal part of Pol linked to the C terminus of the proteinase sequence (Fig.  1) . Moreover, pPROT3423 was amplified from human blood lymphocyte DNA and subsequent sequence analysis revealed identity to published sequences of HERV-K10 (Ono et al., 1986 ; data not shown). Construct pT7-pro0.7 consists of the proteinase sequences with additional sequences at the 3' and 5' ends, driven by the bacterial T7 promoter (Fig. 1) . Expression ofpT7-pro0.7 in E. coli BL21DE3 resulted in the autocatalytic cleavage of the pT7-pro0. (Ono et al., 1986; Mueller-Lantzsch et al., 1993; L6wer et al., 1993) . All constructs except pT7-pro0.7 and pSPTgag-prot were expressed as TrpE fusion proteins in E. coli. TrpE is denoted by open boxes at the N terminus of the constructs, pT7-pro0.7 was expressed as non-fusion protein in E. coli and pSPTgag-prot was used for in vitro translation. Sequences within the dashed lines encode the HERV-K proteinase. Numbers at the top represent nucleotide positions of the indicated genes in the virus genome (Ono et al., 1986) . Plasmids pKP1.0 and pKP1.3 have been described previously Sauter et al., 1995) ; construct pK-PROT0.3 was generated by PCR amplification of a fragment from pKP 1.3 and insertion into the pATH 1 expression vector (Koerner et al., 1991) . pPROT3423 contains a DNA fragment from the prt pol region amplified from genomic DNA of a human volunteer. Construct pT7-pro0.7 was subcloned from pKP1.3 by insertion into vector pET3a (Rosenberg et al., 1987) . Plasmid pSPTgag-prot was subcloned from pKG-P and inserted into the pSPT vector (Boehringer Mannheim).
generation of an 18 kDa fragment (Fig. 2a) . Consequently, treatment of E. coli BL21DE3 harbouring pT7-pro0.7 with increasing concentrations of the proteinase inhibitor Ro31-8959 (Roberts et al., 1990) led to the gradual disappearance of the 18 kDa fragment and an increase in immunoreactive proteins of 20 and 23 kDa. It is likely that the 23 kDa signal corresponds to the primary translation product whereas the 20 kDa protein is cleaved at the C terminus only. It should be pointed out that the Ro31-8959 inhibitor has a K s (dissociation constant for the enzyme inhibitor complex) for the human immunodeficiency virus type 1 (HIV-1) proteinase in the low nanomolar range. Therefore, cultivation of HIV-1 proteinase-expressing bacteria in the presence of this inhibitor at a concentration of 1 ~tM suffices to cause complete loss of activity (H.-G. Krfiusslich, unpublished results). In contrast, no significant inhibition of cellular aspartic proteinases has been detected, even at concentrations of up to 100 laMRo31-8959 (Roberts et al., 1990) , indicating that this inhibitor acts specifically on virus proteinases and therefore suggesting that the inhibition of HERV-K proteinase precursor processing is indeed caused by inhibition of the virus proteinase. However, the different concentrations of the inhibitor required to fully inactivate HIV-1 and HERV-K proteinases likely reflects different substrate specificities (see below). We have shown earlier that at early time-points after expression of plasmid pKP1.3, which in contrast to pT7-pro0.7 contains the proteinase sequences linked to (Studier & Moffatt, 1986 ) expressing the plasmid pT7-pro0.7 were treated with inhibitor Ro31-8959 (Roberts et al., 1990) at the indicated concentrations. Aliquots were removed at the time of expression induction (0 h) and 3 h after induction with IPTG and were analysed by immunoblotting using rabbit polyclonal antiserum against HERV-K proteinase. Antiserum was generated against the protein expressed by pPROT0.3 following described procedures (Sauter & Mueller-Lantzsch, 1987; MuellerLantzsch et al., 1993) and was diluted 1 : 1000. HERV-K-specific proteins are marked by arrows. The HERV-K proteinase appears as an 18 kDa protein. (b) Comparison of expression of different constructs. E. coli BL21DE3 (Studier & Moffatt, 1986) was transformed with the expression vector pATH and the constructs pPROT3423 and pKPI.3. The bacteria were grown and induced as described earlier (Spindler et al., 1984) . After 1 h, protein extracts were analysed by immunoblotting using the proteinase antiserum as described in (a). The antiserum was diluted 1 : 100 and preincubated with bacterial extracts containing TrpE before usage. Arrows denote the 18 and 16 kDa proteinases.
upstream gag sequences as in vivo, a 53 kDa primary translation product is detected by our HERV-K Gag antiserum . With increasing time, this precursor appeared to be proteoIytically cleaved. In order to detect the presumed HERV-K proteinase expressed from pKP1.3, we generated and employed a HERV-K proteinase-specific antiserum. The proteinase appeared as an 18kDa protein in the immunoblot (Fig. 2b) . Finally, the HERV-K proteinase from pPROT3423, lacking the N-terminal amino acid residues in comparison to the pKP1.3 translation product, was examined (Fig. 1) . This enzyme was also capable of excising itself autocatalytically from its precursor. However, and in contrast to the proteinase signal generated upon expression of pKP1.3 and pT7-pro0.7, a proteinase signal of only 16kDa could be detected (Fig. 2b) . The lower molecular mass most probably results from the N-terminal deletion in the proteinase expressed from pPROT3423.
We next wished to demonstrate that bacterially expressed HERV-K proteinase is capable of processing in trans the Gag protein of the virus from a virus polyprotein. Therefore the plasmid pSTPgag-prot was linearized within the proteinase sequence and the DNA was used in a combined in vitro transcription-translation kit (Promega). Proteins were labelled with [aSS]methionine following standard procedures. An 80 kDa protein corresponding to full-length Gag was obtained (Fig. 3a) . No proteins were detected in the control without DNA (data not shown). Bacterial extracts were prepared as described before (Kr/iusslich et al., 1988) .
Incubation of the in vitro-translated HERV-K Gag substrate with a bacterial extract containing the 18 kDa proteinase expressed from pKP 1.3 resulted in cleavage of Gag into major 39 and 30 kDa and minor 26, 22 and 21 kDa subspecies (Fig. 3 a) . The relatively weak labelling of the minor products is most likely a result of a lower methionine content. Similarly, proteinase extract containing the 16kDa proteinase expressed from pPROT3423 gave rise to the same specific fragments, indicating that both the 18 and 16 kDa proteins are Cleavage reactions were carried out for 8 h or more as indicated at 30 °C in a final volume of 20 pl, using 10 pl of in vitro-translated Gag as substrate and 10 pl of the bacterial lysate containing either the HERV-K proteinase or a control plasmid. We used 10 gl of the reaction mixture for analysis on SDS PAGE. Inhibition experiments with pepstatin A or DMSO, the solvent agent for the inhibitor, as controls were performed at the indicated concentrations. (a) In vitrotranslated Gag was mixed either with buffer only, with the 18 kDa proteinase from pKP1.3 or with the 16 kDa proteinase encoded by pPROT3423 (i). Specific cleavage products are marked by arrows. (ii) Immunoprecipitation (IP) of Gag mixed with bacterial lysates containing proteinase from pKP1.3 was performed with polyclonal antiserum generated against HERV-K Gag . +, Similar cleavage products were observed; -, control without antiserum. (b) The in vitro-translated Gag was incubated either with the HERV-K proteinase (pKP1.3), with inactivated proteinase (pKP1.0), with buffer or with extracts from bacteria harbouring the empty expression vector. Arrows denote specific cleavage products. (c) Incubations of pKP1.3-expressed proteinase with in vitro-translated Gag were treated with varying amounts of the specific proteinase inhibitor pepstatin A or DMSO as control. Again, specific cleavage products are indicated by arrows. f u n c t i o n a l l y e q u i v a l e n t (Fig 3a) . C l e a v e d p r o d u c t s a p p e a r e d first a f t e r 4 h o f i n c u b a t i o n . S u b s e q u e n t i m m u n o p r e c i p i t a t i o n s w i t h a p o l y c l o n a l a n t i b o d y c o nf i r m e d t h e i d e n t i t y o f t h e G a g b r e a k d o w n p r o d u c t s (Fig  3a) . I n c o n t r a s t to in vitro-translated H E R V -K G a g , G a g p r o t e i n f r o m H I V -1 w a s n o t c l e a v e d a n d t h e r e f o r e seems to not to be a substrate of the proteinase in these experiments. Furthermore the HERV-K Gag was not processed by the HIV-1 proteinase. This indicates that HERV-K and HIV-1 proteinases have different substrate specificities (data not shown).
To exclude the possibility that the observed specific cleavage products of the Gag precursor were either caused by contaminating proteinases or were mimicked by translation products from contaminating RNAs, several control experiments were performed. Firstly, the Gag substrate was incubated with (i) the bacterial extract containing the truncated and therefore inactive HERV-K proteinase encoded by pKP1.0; (ii) TrpE extract; and (iii) incubation buffer only (Fig. 3 b) . Even after 21 h of incubation no specific Gag fragments could be detected. Secondly, the HERV-K proteinase-containing bacterial extracts were incubated with RNase H (4 lag/lal), which degrades contaminiating RNAs, for 20 min. After incubation of the RNase H-treated bacterial extracts with the Gag substrate we still observed smaller Gag proteins. Therefore the specific Gag protein fragments do not originate from contaminating newly translated RNAs but from the full-length Gag substrate by HERV-K proteinase cleavage (data not shown).
In order to determine whether Gag cleavage by HERV-K proteinase was specifically inhibited by the aspartic proteinase inhibitor pepstatin A, Gagproteinase mixtures were incubated with increasing concentrations of the inhibitor or alternatively with DMSO. At a concentration of 1 mM the enzyme activity was completely repressed, and even concentrations of 0"5mM or 0'lmM sufficed to partially repress the proteinase activity (Fig. 3 c) .
In order to optimize the conditions for the proteinase activity we varied different parameters. Neither increasing salt concentrations up to 0"5mM, nor pH changes nor temperature shifts had substantial effects on the activity of the enzyme. At pH 6"5 a two-to threefold higher activity than at pH 6"0 or 7-0 was observed. A temperature shift from 30 °C to 37 °C resulted in a twoto threefold decrease in activity (data not shown).
Our data have shown that a proteinase expressed from the HERV-K ORF 3 is capable of processing the same substrate in vitro that has already been demonstrated to be processed in vivo in cell types expressing HERV-K (Sauter et al., 1995) . Since we were able to demonstrate specificity of this enzymatic reaction in vitro, our data suggest that it is indeed the proteinase of the cellular HERV-K that is responsible for the processing of Gag in vivo.
